加納 美優

論文

• Near-infrared Photoimmunotherapy Targeting Canine Mammary Tumors: Comparative Oncology for Overcoming Human Breast Cancer.

  Motofumi Suzuki, Aki Furusawa, Hiroshi Yamamoto, K O Kitamura, Makoto Kano, Miyu Kano, Seiichiro Takao, Yukinari Kato, Amy K Leblanc, Peter L Choyke …

  Anticancer research 46(8) 4171-4182 2026年8月
• Understanding tumor microenvironment dynamics and immune checkpoint inhibitor efficacy following mEGFR-targeted near-infrared photoimmunotherapy.

  Seiichiro Takao, Aki Furusawa, Makoto Kano, Hiroshi Yamamoto, Miyu Kano, Motofumi Suzuki, Hiroshi Fukushima, Shuhei Okuyama, Ko Kitamura, Peter L Choyke …

  Cancer letters 650 218515-218515 2026年7月10日
• Epidermal growth factor receptor-targeted near-infrared photoimmunotherapy for malignant pleural mesothelioma.

  Miyu Kano, Aki Furusawa, Seiichiro Takao, Motofumi Suzuki, Makoto Kano, Hiroshi Yamamoto, Peter L Choyke, Hisataka Kobayashi

  Lung cancer (Amsterdam, Netherlands) 217 109427-109427 2026年7月
• Human epidermal growth factor receptor 3-targeted near-infrared photoimmunotherapy in a xenograft mouse model of breast cancer.

  Makoto Kano, Aki Furusawa, Hiroshi Fukushima, Seiichiro Takao, Shuhei Okuyama, Hiroshi Yamamoto, Motofumi Suzuki, Ko Kitamura, Miyu Kano, Peter L Choyke …

  BMC cancer 26(1) 2026年5月18日
• Combined CD25-targeted near infrared photoimmunotherapy (NIR-PIT) and intratumor IL-15 enhance the effectiveness of anti-PD-1 immunotherapy.

  Makoto Kano, Aki Furusawa, Hiroshi Fukushima, Seiichiro Takao, Shuhei Okuyama, Hiroshi Yamamoto, Motofumi Suzuki, Miyu Kano, Ko Kitamura, Peter L Choyke …

  Cancer immunology, immunotherapy : CII 75(1) 7-7 2025年12月18日
• EpCAM-targeted near-infrared photoimmunotherapy (NIR-PIT) for the treatment of breast cancer.

  Aki Furusawa, Seiichiro Takao, Motofumi Suzuki, Makoto Kano, Hiroshi Yamamoto, Miyu Kano, Peter Choyke, Hisataka Kobayashi

  Annals of medicine 57(1) 2540599-2540599 2025年12月
• Preserved host immunity with intercellular adhesion molecule-1 (ICAM-1)-targeted near-infrared photoimmunotherapy (NIR-PIT) in the treatment of triple-negative breast cancer and other malignancies.

  Seiichiro Takao, Hideyuki Furumoto, Aki Furusawa, Makoto Kano, Hiroshi Yamamoto, Motofumi Suzuki, Miyu Kano, Peter L Choyke, Hisataka Kobayashi

  Cancer letters 630 217906-217906 2025年10月10日
• Interleukin 15 (IL15)-based near-infrared photoimmunotherapy.

  Motofumi Suzuki, Aki Furusawa, Hiroshi Yamamoto, Makoto Kano, Miyu Kano, Seiichiro Takao, Shuhei Okuyama, Peter L Choyke, Hisataka Kobayashi

  Cancer immunology, immunotherapy : CII 74(9) 295-295 2025年8月31日
• Impact of Vitamin C on Immune Response and Edema Following Near-Infrared Photoimmunotherapy (NIR-PIT).

  Hiroshi Yamamoto, Aki Furusawa, Hiroshi Fukushima, Seiichiro Takao, Motofumi Suzuki, Makoto Kano, Miyu Kano, Shuhei Okuyama, Ko Kitamura, Peter L Choyke …

  Cancer science 116(7) 1836-1846 2025年7月
• Carbonic anhydrase-9-targeted near-infrared photoimmunotherapy as a theranostic modality for clear cell renal cell carcinoma.

  Hiroshi Fukushima, Seiichiro Takao, Aki Furusawa, Motofumi Suzuki, Youfeng Yang, Christopher J Ricketts, Makoto Kano, Shuhei Okuyama, Hiroshi Yamamoto, Miyu Kano …

  International journal of cancer 156(12) 2377-2388 2025年6月15日
• Tissue factor targeted near-infrared photoimmunotherapy: a versatile therapeutic approach for malignancies.

  Seiichiro Takao, Hiroshi Fukushima, Aki Furusawa, Takuya Kato, Shuhei Okuyama, Makoto Kano, Hiroshi Yamamoto, Motofumi Suzuki, Miyu Kano, Peter L Choyke …

  Cancer immunology, immunotherapy : CII 74(2) 48-48 2025年1月3日
• Near-infrared duocarmycin photorelease from a Treg-targeted antibody-drug conjugate improves efficacy of PD-1 blockade in syngeneic murine tumor models.

  Hiroshi Fukushima, Aki Furusawa, Seiichiro Takao, Ebaston Thankarajan, Michael P Luciano, Syed Muhammad Usama, Makoto Kano, Shuhei Okuyama, Hiroshi Yamamoto, Motofumi Suzuki …

  Oncoimmunology 13(1) 2370544-2370544 2024年
• 間質性肺疾患を合併した抗OJ抗体陽性皮膚筋炎の1例

  池田 智行, 加納 美優, 牧野 智, 小林 忠弘, 大石 京介, 濱口 儒人, 松下 貴史, 伊川 友香

  日本皮膚科学会雑誌 132(5) 1345-1345 2022年5月
• Immunomodulating role of the JAKs inhibitor tofacitinib in a mouse model of bleomycin-induced scleroderma

  Wah Wah Aung, Chenyang Wang, Jia Xibei, Motoki Horii, Kie Mizumaki, Miyu Kano, Ai Okamura, Tadahiro Kobayashi, Takashi Matsushita

  Journal of Dermatological Science 101(3) 174-184 2021年3月
• Suppression of IL-23-mediated psoriasis-like inflammation by regulatory B cells.

  Kie Mizumaki, Motoki Horii, Miyu Kano, Akito Komuro, Takashi Matsushita

  Scientific reports 11(1) 2106-2106 2021年1月22日
• Anti‐transcriptional intermediary factor 1‐γ antibody as a biomarker in patients with dermatomyositis

  The Journal of Dermatology 47(1) 64-68 2020年1月1日 査読有り
• Attenuation of murine sclerodermatous models by the selective S1P1 receptor modulator cenerimod

  Miyu Kano, Tadahiro Kobayashi, Mutsumi Date, Momoko Tennichi, Yasuhito Hamaguchi, Daniel S Strasser, Kazuhiko Takehara, Takashi Matsushita

  Scientific Reports 9(1) 2019年12月1日 査読有り
• Elevated serum B‐cell activating factor levels in patients with dermatomyositis: Association with interstitial lung disease

  Takashi Matsushita, Tadahiro Kobayashi, Miyu Kano, Yasuhito Hamaguchi, Kazuhiko Takehara

  The Journal of Dermatology 46(12) 1190-1196 2019年12月1日 査読有り
• BAFF inhibition attenuates fibrosis in scleroderma by modulating the regulatory and effector B cell balance

  Takashi Matsushita, Tadahiro Kobayashi, Kie Mizumaki, Miyu Kano, Tomoyo Sawada, Momoko Tennichi, Ai Okamura, Yasuhito Hamaguchi, Yoichiro Iwakura, Minoru Hasegawa …

  Science Advances 4(7) eaas9944 2018年7月11日 査読有り
• Blockade of p38 Mitogen-Activated Protein Kinase Inhibits Murine Sclerodermatous Chronic Graft-versus-Host Disease

  Takashi Matsushita, Mutsumi Date, Miyu Kano, Kie Mizumaki, Momoko Tennichi, Tadahiro Kobayashi, Yasuhito Hamaguchi, Minoru Hasegawa, Manabu Fujimoto, Kazuhiko Takehara

  AMERICAN JOURNAL OF PATHOLOGY 187(4) 841-850 2017年4月 査読有り